CollPlant Biotechnologies Ltd
CLGN- Exchange
- Nasdaq
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- SEC CIK
- 0001631487
No open-market purchases or sales by CollPlant Biotechnologies Ltd insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $582.4K in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding CollPlant Biotechnologies Ltd changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 21 | 18 | −3 |
| Shares | 1.57M | 1.58M | +6.00K (+0.4%) |
| Value | $10.7M | $13.1M | +$2.37M (+22.1%) |
New holders (2)
Institutions that held CollPlant Biotechnologies Ltd at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Credit Suisse AG | 6,100 | $50.9K | 0.00% |
| GWM Advisors LLC | 400 | $3 | 0.00% |
Sold out (5)
Institutions that held CollPlant Biotechnologies Ltd at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| LPL Financial LLC | 28,070 | $191.0K |
| Jane Street Group, LLC | 13,265 | $90.0K |
| FNY Investment Advisers, LLC | 5,250 | $35.0K |
| Cohanzick Management, LLC | 2,000 | $14.0K |
| Simplex Trading, LLC | 585 | $3.00K |